President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine. That drug and other psychedelics remain banned under the government’s most restrictive category for illegal, high-risk drugs. But the administration is taking steps to ease restrictions and spur research on using the drugs for medical purposes, including conditions such as severe depression. Trump signed an executive order Saturday that he says will help “dramatically accelerate” access to potential treatments. Veteran organizations and others say ibogaine shows promise for conditions like post-traumatic stress disorder and opioid addiction. But ibogaine is known to sometimes trigger potentially fatal heart problems.

Federal inspectors report a concern with nursing homes in Ohio discharging patients to homeless shelters. A recent case involved a woman with multiple health issues being left at a shelter by Eastland Rehabilitation and Nursing Center. Staff failed to find her a psychiatric bed, leaving her at the shelter where she was initially refused entry. The administrator at Eastland declined to return phone calls about the inspection. The situation reflects a broader issue as nursing homes face financial pressures. Experts emphasize the need for state oversight and resources to address the problem, ensuring discharges are safe and appropriate.